|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07H 19/12 | (2006.01) |
| (11) | Number of the document | 1610784 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04721074.5 |
| Date of filing the European patent application | 2004-03-16 | |
| (97) | Date of publication of the European application | 2006-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-06 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (86) | Number | PCT/US2004/007895 |
| Date | 2004-03-16 |
| (87) | Number | WO 2004/082619 |
| Date | 2004-09-30 |
| (30) | Number | Date | Country code |
| 390578 | 2003-03-17 | US |
| (72) |
IONESCU, Dumitru, US
BLUMBERGS, Peter, US
SELVEY, Lee Alani, US
|
| (73) |
Celgene International Sarl,
Route de Perreux 1, 2017 Boudry,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 5-Azacitidino formos |
| FORMS OF 5-AZACYTIDINE |
| Payment date | Validity (years) | Amount | |
| 2018-03-02 | 15 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2018-03-30 |